Shivaani Kummar

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Tyrosine Kinase

Metastatic Renal Cell Carcinoma

Artificial Intelligence

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

JCO clinical cancer informatics

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Apostolia-Maria Tsimberidou, Farah A Alayli, Kwame Okrah, Alexandra Drakaki, Danny N Khalil, Shivaani Kummar, Saad A Khan, Frank Stephen Hodi, David Y Oh, Christopher R Cabanski, Shikha Gautam, Stefanie L Meier, Meelad Amouzgar, Shannon M Pfeiffer, Robin Kageyama, Enjun Yang, Marko Spasic, Michael T Tetzlaff, Wai Chin Foo, Travis J Hollman, Yanyun Li, Matthew J Adamow, Phillip Wong, Jonni S Moore, Sharlene Velichko, Richard O Chen, Dinesh Kumar, Samantha Bucktrout, Ramy Ibrahim, Ute Dugan, Lisa Salvador, Vanessa M Hubbard-Lucey, Jill O'Donnell-Tormey, Sandra Santulli-Marotto, Lisa H Butterfield, Diane M Da Silva, Justin Fairchild, Theresa M LaVallee, Lacey J Padrón, Padmanee Sharma
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer. The Journal of experimental medicine 221 (10) (2024)
Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Shivaani Kummar, Ruixiao Lu
Using Radiomics in Cancer Management. JCO precision oncology 8 (2024)
Shivaani Kummar, Ruixiao Lu
Using Radiomics in Cancer Management. JCO precision oncology 8 (2024)
Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, a FLT3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Apostolia-Maria Tsimberidou, Farah A Alayli, Kwame Okrah, Alexandra Drakaki, Danny N Khalil, Shivaani Kummar, Saad A Khan, Frank Stephen Hodi, David Y Oh, Christopher R Cabanski, Shikha Gautam, Stefanie L Meier, Meelad Amouzgar, Shannon M Pfeiffer, Robin Kageyama, Enjun Yang, Marko Spasic, Michael T Tetzlaff, Wai Chin Foo, Travis J Hollman, Yanyun Li, Matthew J Adamow, Phillip Wong, Jonni S Moore, Sharlene Velichko, Richard O Chen, Dinesh Kumar, Samantha Bucktrout, Ramy Ibrahim, Ute Dugan, Lisa Salvador, Vanessa M Hubbard-Lucey, Jill O'Donnell-Tormey, Sandra Santulli-Marotto, Lisa H Butterfield, Diane M Da Silva, Justin Fairchild, Theresa M LaVallee, Lacey J Padrón, Padmanee Sharma
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer. The Journal of experimental medicine 221 (10) (2024)
Anthony W Tolcher, Joshua D Brody, Nishanthan Rajakumaraswamy, Michelle R Kuhne, Torsten Trowe, Anees M Dauki, Shantheri Pai, Ling Han, Kai-Wen Lin, Michael Petrarca, Shivaani Kummar
Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Christopher T Chen, Vishesh Khanna, Shivaani Kummar, Raghad M Abdul-Karim, David Sommerhalder, Anthony W Tolcher, Naoto Tada Ueno, S Lindsey Davis, Douglas W Orr, Erika Paige Hamilton, Manish R Patel, Alexander I Spira, Shekeab Jauhari, Vaia Florou, Maureen Duff, Rongda Xu, Jian Wang, Shravani R Barkund, Haiying Zhou, Aleksandr Pankov, Wayne Kong, Nadine S Jahchan, Erica L Jackson, Jessica D Sun, Melissa R Junttila, Pratik S Multani, Anneleen Daemen, Edna Chow-Maneval, Pamela N Munster
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors. Cancer research communications (2024)
Savitri Krishnamurthy, Parag Jain, Debasish Tripathy, Roland L Bassett, Ramandeep Randhawa, Hassan Muhammad, Wei Huang, Hua Yang, Shivaani Kummar, George Wilding, Rajat Roy
Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool. JCO clinical cancer informatics 7 (2023)
Savitri Krishnamurthy, Parag Jain, Debasish Tripathy, Roland L Bassett, Ramandeep Randhawa, Hassan Muhammad, Wei Huang, Hua Yang, Shivaani Kummar, George Wilding, Rajat Roy
Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool. JCO clinical cancer informatics 7 (2023)
Shivaani Kummar, Lin Shen, David S Hong, Ray McDermott, Vicki L Keedy, Michela Casanova, George D Demetri, Afshin Dowlati, Soledad Gallego Melcón, Ulrik N Lassen, Serge Leyvraz, Tianshu Liu, Victor Moreno, Jyoti Patel, Tejas Patil, Atrayee Basu Mallick, Nuno Sousa, Makoto Tahara, David S Ziegler, Ricarda Norenberg, Pierre Arvis, Nicoletta Brega, Alexander Drilon, Daniel S W Tan
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas. Cancer (2023)
Alexander E Drilon, Daniel Shao-Weng Tan, Ulrik N Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D Patel, Lee S Rosen, Benjamin Solomon, Ricarda Norenberg, Laura Dima, Nicoletta Brega, Lin Shen, Victor Moreno, Shivaani Kummar, Jessica J Lin
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers. JCO precision oncology 6 (2022)
Jie Chen, Ying Lu, Shivaani Kummar
Increasing patient participation in oncology clinical trials. Cancer medicine (2022)
James Nguyen, Naoko Takebe, Shivaani Kummar, Albiruni Abdul Razak, Sant P Chawla, Suzanne George, Shreyaskumar R Patel, Mary Louise Keohan, Sujana Movva, Geraldine O'Sullivan Coyne, Khanh T Do, Lamin Jawara, Brooke Augustine, Seth M Steinberg, Laura Kuhlmann, Susan Percy Ivy, James H Doroshow, Helen X Chen
Randomized Phase 2 Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Wei Huang, Ramandeep Randhawa, Parag Jain, Samuel Hubbard, Jens Eickhoff, Shivaani Kummar, George Wilding, Hirak S Basu, Rajat Roy
A Novel Artificial Intelligence-Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers. JCO clinical cancer informatics 6 (2022)
Alexander Honkala, Sanjay V Malhotra, Shivaani Kummar, Melissa R Junttila
Harnessing the predictive power of preclinical models for oncology drug development. Nature reviews. Drug discovery (2021)
Giovanna Speranza, Larry Anderson, Alice P Chen, Khanh Do, Michelle Eugeni, Marcie Weil, Larry Rubinstein, Eva Majerova, Jerry Collins, Yvonne Horneffer, Lamin Juwara, Jennifer Zlott, Rachel Bishop, Barbara A Conley, Howard Streicher, Joseph Tomaszewski, James H Doroshow, Shivaani Kummar
First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile. Investigational new drugs 36 (2) (2017)
Nam Q Bui, Shivaani Kummar
Evolution of early phase clinical trials in oncology. Journal of molecular medicine (Berlin, Germany) 96 (1) (2017)